Expand CKPT Menu
CKPT MENU

CKPT Stock Summary and Trading Ideas (Checkpoint Therapeutics | NASDAQ:CKPT)

Charts for Today's Stock Price and Implied Volatility in Checkpoint Therapeutics

29-Nov-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for CKPT by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Checkpoint Therapeutics (CKPT) Frequently Asked Questions

What does Checkpoint Therapeutics do?

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

What symbol and exchange does Checkpoint Therapeutics shares trade?

Checkpoint Therapeutics trades on the NASDAQ stock market under the symbol CKPT.

What is Checkpoint Therapeutics stock price doing today?

As of November 29, 2024, CKPT stock price climbed to $4.39 with 750,699 million shares trading.

What is Checkpoint Therapeutics's Beta?

CKPT has a beta of 1.06, meaning it tends to be more sensitive to market movements. CKPT has a correlation of 0.02 to the broad based SPY ETF.

How much is Checkpoint Therapeutics worth?

CKPT has a market cap of $214.37 million. This is considered a Small Cap stock.

How much money does Checkpoint Therapeutics make?

Last quarter Checkpoint Therapeutics reported $0 in Revenue and -$.23 earnings per share. This fell short of revenue expectation by $-10,000 and missed earnings estimates by -$.08.

What is the highest and lowest price Checkpoint Therapeutics traded in the last 3 year period?

In the last 3 years, CKPT traded as high as $32.71 and as low as $1.30.

What are the top ETFs holding Checkpoint Therapeutics?

The top ETF exchange traded funds that CKPT belongs to (by Net Assets): VTI, VXF, IWC.

Is Checkpoint Therapeutics (CKPT) a good investment?

CKPT has outperformed the market in the last year with a price return of +71.8% while the SPY ETF gained +34.1%. CKPT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +87.6% and +28.0%, respectively, while the SPY returned +8.2% and +2.9%, respectively.

What are the support and resistance levels for Checkpoint Therapeutics (CKPT)?

CKPT support price is $4.04 and resistance is $4.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CKPT shares will trade within this expected range on the day.